Company News

Getz Healthcare Philippines Unveils Cre8 Evo: A Revolutionary Drug Eluting Stent

Published on February 2025

Getz Healthcare Philippines is proud to announce the successful launch of Cre8 Evo, an innovative Drug Eluting Stent, in the Philippines. Cre8 Evo sets a new benchmark in both efficacy and safety, featuring a polymer-free platform coated with Bio Inducer Surface (BIS), ensuring superior performance.

To mark this official launch, Getz Healthcare welcomed world-renowned Interventional Cardiologist, Dr. Scott Harding from Wellington, New Zealand. From February 10-12, 2025, Dr. Harding, alongside the Getz Healthcare team, conducted a series of hospital visits, engaging in complex case discussions with fellows and consultants, as well as providing proctorship for complex PCI cases such as Chronic Total Occlusions (CTO).

The event culminated in a scientific lecture delivered by Dr. Harding at Novotel Manila, which was attended by leading Consultants, Key Opinion Leaders, and healthcare partners in the field of Interventional Cardiology.

We would like to extend our sincere gratitude to St. Luke’s Medical Center Quezon City and Bonifacio Global City, Philippine Heart Center, Cardinal Santos Medical Center, and The Medical City for their invaluable partnership in making this launch a success At Getz Healthcare, we remain committed to bringing the most innovative medical devices to the Philippines, addressing critical healthcare gaps, and ultimately saving lives.

 

Getz Healthcare is proud to be recognized as the leading distributor of medical equipment, devices and consumables, in Asia Pacific.

Our full-service distribution capabilities provide end-to-end representation of our business partners’ products, while delivering comprehensive service and solutions to our customers in all the countries we serve. Learn more

All product information listed on this site are for healthcare professionals only. Descriptions and specifications of the products listed on this site are provided by the manufacturer.